Baxter Nicholas W 4
4 · Lexaria Bioscience Corp. · Filed Sep 2, 2021
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Award
Stock Options
2021-09-01+1,900→ 8,400 totalExercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying)
Holdings
- 6,500
Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 11,000
common shares
- 1,500
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying)